Published in J Immunol on October 15, 2000
Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression. J Allergy Clin Immunol (2010) 1.78
Investigation of HIFU-induced anti-tumor immunity in a murine tumor model. J Transl Med (2007) 1.33
Alarmins, inflammasomes and immunity. Biomed J (2013) 1.13
Purinergic mechanism in the immune system: A signal of danger for dendritic cells. Purinergic Signal (2005) 1.10
Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs. Biochem Biophys Res Commun (2005) 1.07
Possible effects of microbial ecto-nucleoside triphosphate diphosphohydrolases on host-pathogen interactions. Microbiol Mol Biol Rev (2008) 1.07
Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils. Immunology (2004) 1.01
Development of a new protocol for 2-day generation of mature dendritic cells from human monocytes. Biol Proced Online (2003) 0.97
Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation. Immunology (2003) 0.97
TGF-beta1 dampens the susceptibility of dendritic cells to environmental stimulation, leading to the requirement for danger signals for activation. Immunology (2009) 0.94
Purinergic signalling and immune cells. Purinergic Signal (2014) 0.94
A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines. BMC Cancer (2007) 0.94
P2 purinergic receptor modulation of cytokine production. Purinergic Signal (2007) 0.93
Detecting adenosine triphosphate in the pericellular space. Interface Focus (2013) 0.92
Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses. Purinergic Signal (2013) 0.92
Uncoupling of ATP-mediated calcium signaling and dysregulated interleukin-6 secretion in dendritic cells by nanomolar thimerosal. Environ Health Perspect (2006) 0.90
Direct contact of platelets and their released products exert different effects on human dendritic cell maturation. BMC Immunol (2008) 0.88
Extracellular ATP reduces HIV-1 transfer from immature dendritic cells to CD4+ T lymphocytes. Retrovirology (2008) 0.87
Identification of ATPAF1 as a novel candidate gene for asthma in children. J Allergy Clin Immunol (2011) 0.86
SOCS2 influences LPS induced human monocyte-derived dendritic cell maturation. PLoS One (2009) 0.86
Maturation of dendritic cell precursors into IL12-producing DCs by J-LEAPS immunogens. Cell Immunol (2010) 0.84
Enhanced maturation and functional capacity of monocyte-derived immature dendritic cells by the synthetic immunomodulator Murabutide. Immunology (2001) 0.82
Differential responses of cord and adult blood-derived dendritic cells to dying cells. Immunology (2005) 0.82
CD39 expression by hepatic myeloid dendritic cells attenuates inflammation in liver transplant ischemia-reperfusion injury in mice. Hepatology (2013) 0.82
The influence of Ouabain on human dendritic cells maturation. Mediators Inflamm (2014) 0.77
IL-12 and IL-4 activate a CD39-dependent intrinsic peripheral tolerance mechanism in CD8(+) T cells. Eur J Immunol (2016) 0.76
Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi. Antimicrob Agents Chemother (2015) 0.76
Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy. Viruses (2015) 0.76
Shaping immune responses through the activation of dendritic cells' P2 receptors. Purinergic Signal (2006) 0.76
Generation of functional monocyte-derived fast dendritic cells suitable for clinical application in the absence of interleukin-6. Cytotechnology (2011) 0.75
Mechanisms of anti-carcinogenesis by indole-3-carbinol. Studies of enzyme induction, electrophile-scavenging, and inhibition of aflatoxin B1 activation. Biochem Pharmacol (1990) 0.75
Sjögren's Syndrome Antigen B Acts as an Endogenous Danger Molecule to Induce Interleukin-8 Gene Expression in Polymorphonuclear Neutrophils. PLoS One (2015) 0.75
The Role of Purine Metabolites as DAMPs in Acute Graft-versus-Host Disease. Front Immunol (2016) 0.75
Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol (2001) 3.64
Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol (1994) 3.51
Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol (2001) 3.34
Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis (1990) 3.20
Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest (2001) 2.84
Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci U S A (2005) 2.75
Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol (1999) 2.52
The GroE chaperonin machine is a major modulator of the CIRCE heat shock regulon of Bacillus subtilis. EMBO J (1997) 2.50
Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am J Physiol Regul Integr Comp Physiol (2001) 2.16
High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine (2000) 1.92
Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity (1995) 1.83
Differences in the synthesis and kinetics of release of interleukin 1 alpha, interleukin 1 beta and tumor necrosis factor from human mononuclear cells. Eur J Immunol (1989) 1.72
Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro. J Leukoc Biol (1988) 1.70
The activation of female sex hormones: alpha-Oestradiol and its di-esters. Biochem J (1938) 1.69
C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha. J Exp Med (1988) 1.67
Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr (1991) 1.57
Mitochondrial function in the oxygen depleted and reoxygenated myocardial cell. Cardiovasc Res (1994) 1.57
Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity. Immunology (1993) 1.56
The activation of female sex hormones: Oestrone and its esters. The output of activity and efficiency coefficient. Biochem J (1938) 1.49
Pancreatic carcinoma in azaserine-treated rats: induction, classification and dietary modulation of incidence. Cancer (1981) 1.47
Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry. Horm Metab Res (2010) 1.42
C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma. J Immunol (1987) 1.41
Adenosine kinase inhibitor GP515 improves experimental colitis in mice. J Pharmacol Exp Ther (2001) 1.40
[Fish oil to prevent recurrence of Crohn disease?]. Z Gastroenterol (1997) 1.39
Novel and enhanced IL-1 gene expression in autoimmune mice with lupus. J Immunol (1988) 1.37
Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol Today (1997) 1.34
Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. J Clin Endocrinol Metab (2009) 1.30
Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production. J Leukoc Biol (1998) 1.30
CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens. J Leukoc Biol (2001) 1.30
Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo. J Immunol (2000) 1.29
The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells. Int J Immunopharmacol (1993) 1.23
Failure of potassium siphoning by Müller cells: a new hypothesis of perfluorocarbon liquid-induced retinopathy. Invest Ophthalmol Vis Sci (2000) 1.22
Interleukin-1 beta in human plasma: optimization of blood collection, plasma extraction, and radioimmunoassay methods. Lymphokine Res (1988) 1.22
Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review. Breast Cancer Res Treat (2006) 1.21
Development and use of a radioimmunoassay for human interleukin-1 beta. Lymphokine Res (1987) 1.21
Modular structure of the trigger factor required for high activity in protein folding. J Mol Biol (1997) 1.21
In vitro desensitization to lipopolysaccharide suppresses tumour necrosis factor, interleukin-1 and interleukin-6 gene expression in a similar fashion. Immunology (1992) 1.20
Slit-lamp-adapted optical coherence tomography of the anterior segment. Graefes Arch Clin Exp Ophthalmol (2000) 1.19
Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice. J Pharmacol Exp Ther (2000) 1.19
[Clinical practice guideline on diagnosis and treatment of Crohn's disease]. Z Gastroenterol (2008) 1.19
Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity. Cell (1997) 1.18
Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines. Cancer Res (2001) 1.17
Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole. Infection (1994) 1.16
Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis (2005) 1.15
What you eat is what you get: Novel Campylobacter models in the quadrangle relationship between nutrition, obesity, microbiota and susceptibility to infection. Eur J Microbiol Immunol (Bp) (2011) 1.15
Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease. Clin Exp Immunol (2004) 1.14
European study on orthopaedic status of haemophilia patients with inhibitors. Haemophilia (2007) 1.14
Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice. Gut (2008) 1.13
Glaucoma progression is associated with decreased blood flow velocities in the short posterior ciliary artery. Br J Ophthalmol (2006) 1.13
In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination. J Infect Dis (1998) 1.11
Dynamic association of trigger factor with protein substrates. J Mol Biol (2001) 1.11
Toll-like receptor expression and response to specific stimulation in adipocytes and preadipocytes: on the role of fat in inflammation. Ann N Y Acad Sci (2006) 1.09
Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model. Gut (2007) 1.08
Corneal optical coherence tomography before and immediately after excimer laser photorefractive keratectomy. Am J Ophthalmol (2000) 1.08
Longevity of adult ventricular rat heart muscle cells in serum-free primary culture. J Mol Cell Cardiol (1991) 1.06
Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN. J Leukoc Biol (2002) 1.06
Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesis. Scand J Immunol (1997) 1.03
Anti-inflammatory properties of unfractioned heparin in patients with highly active ulcerative colitis: a pilot study. Am J Gastroenterol (1997) 1.02
Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism. J Cell Biochem (2001) 1.00
Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort. Allergy (2011) 1.00
Defining the role of T cell-derived leptin in the modulation of hepatic or intestinal inflammation in mice. Clin Exp Immunol (2005) 0.99
Tracer test with As(V) under variable redox conditions controlling arsenic transport in the presence of elevated ferrous iron concentrations. J Contam Hydrol (2006) 0.99
Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta. Eur J Immunol (2001) 0.98
Metabolism of exogenous substrates by coronary endothelial cells in culture. J Mol Cell Cardiol (1990) 0.97
Cyclophilin and trigger factor from Bacillus subtilis catalyze in vitro protein folding and are necessary for viability under starvation conditions. Biochemistry (1998) 0.97
New bioresorbable pin for the reduction of small bony fragments: design, mechanical properties and in vitro degradation. Biomaterials (1996) 0.96
Low-dose calcitriol prevents the rise in 1,84-iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial). Nephrol Dial Transplant (1995) 0.95
Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids. Eur J Immunol (1995) 0.95
First experimental and clinical results with transscleral optical coherence tomography. Ophthalmic Surg Lasers (2000) 0.95
The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia. Chest (1996) 0.94
Glycoprotein and carbohydrate binding protein expression in the placenta in early pregnancy loss. J Reprod Immunol (2010) 0.94
[Spectrum of diagnoses in an internal medicine emergency unit]. Internist (Berl) (2001) 0.94
Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation. J Thorac Cardiovasc Surg (1993) 0.94
Interleukin-1 beta (IL-1 beta), IL-1 receptor antagonist, and TNF alpha production in whole blood. J Leukoc Biol (1992) 0.93
Spread of HIV-2 in India. Lancet (1991) 0.93
The distinct roles of MMP-2 and MMP-9 in acute DSS colitis. Eur J Microbiol Immunol (Bp) (2011) 0.93
Interferon-alpha induces interleukin-18 binding protein in chronic hepatitis C patients. Clin Exp Immunol (2002) 0.93
Adipokine signaling in inflammatory bowel disease. Inflamm Bowel Dis (2009) 0.93
Prevention of the oxygen paradox in hypoxic-reoxygenated hearts. Am J Physiol (1991) 0.93
Functions of FKBP12 and mitochondrial cyclophilin active site residues in vitro and in vivo in Saccharomyces cerevisiae. Mol Biol Cell (1997) 0.92
Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1beta after live yellow fever vaccination. Clin Exp Immunol (2001) 0.92
Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7. J Immunol (1995) 0.92
Crystal structure of a phage library-derived single-chain Fv fragment complexed with turkey egg-white lysozyme at 2.0 A resolution. J Mol Biol (2000) 0.91
Subhemolytic doses of Escherichia coli hemolysin evoke large quantities of lipoxygenase products in human neutrophils. J Biol Chem (1991) 0.90
[Examination of the cornea using optical coherence tomography]. Ophthalmologe (2001) 0.90